Amyris, Inc. (NASDAQ:AMRS)

jkb31 (< 20) Submitted: 3/19/2012 2:00:26 PM : Start Price: $5.33 AMRS Score: -62.76

The steep downward trend of this stock is justified to an extent on the earnings, but recent insider buys and management adjustments for the company give some upside support. Worth a look.

innovol (< 20) Submitted: 2/27/2012 4:46:00 AM : Start Price: $6.53 AMRS Score: -77.46

Advanced Quantitative Momentum Arbitrage (AQMA)
(black box)

oregonpb (68.90) Submitted: 2/16/2012 12:04:36 PM : Start Price: $6.20 AMRS Score: -75.40

Biofuel>> until the company produces for the market it will be speculative, but when it does it might be too late to get in ~early.

powerkiwi (< 20) Submitted: 1/23/2012 4:46:30 PM : Start Price: $10.46 AMRS Score: -99.39

Its a strong company with many potential technologies. Green tech is growing rapidly

GeoSteam (30.17) Submitted: 1/20/2012 11:15:36 PM : Start Price: $10.41 AMRS Score: -98.57

It is a biochemical company which can turn plant sugars into more valuable commodities using designer microbes, an entirely new human capability. The company is ran by idealistic, practical leaders, with special strength in several nations, e.g. Brazil.

phboyer (< 20) Submitted: 9/30/2011 2:16:55 PM : Start Price: $19.85 AMRS Score: -131.21

AMRS is undervalued at these levels. There is resistance at the $20.50 level. If it breaks $21 is could squirt all the way to $30 in no time. They are well backed and respected in the VC community.

korhonen (72.94) Submitted: 2/20/2011 1:48:27 PM : Start Price: $29.97 AMRS Score: -115.59

On the cusp of profitability and have gained capital through the IPO.

EclecticRecluse (77.87) Submitted: 1/30/2011 3:37:38 AM : Start Price: $31.12 AMRS Score: +120.90

Weakening Earnings Opinion

TMFRisingStars (45.55) Submitted: 1/28/2011 11:39:18 AM : Start Price: $31.70 AMRS Score: -120.79

Here's the buy rec:
http://www.fool.com/investing/high-growth/2011/01/27/rising-star-buy-amyris-biotechnologies.aspx

TheGrtGdOM (41.53) Submitted: 11/6/2010 3:01:07 PM : Start Price: $17.38 AMRS Score: -119.49

The long term arc is that oil is going to cost more and more to extract. This company's products OTOH need no refining and have an abundantly available feedstock. They can be shunted into pathways for use as gasoline, diesel, or jet fuel substitutes and exceed the original's performance. And eventually aviation will be charged for its carbon emissions as well, justifying an additional premium for this alternative.

Meanwhile the company will eke by at first by producing other specialty products as they get their production costs down and the costs of oil and associated with its use go up. I suspect that "capital light" may even eventually mean selling just the bugs as IP.

A long term play but worth it for an investor with tolerance for risk and a long term horizon.

notUSA (24.63) Submitted: 11/3/2010 6:43:28 PM : Start Price: $17.15 AMRS Score: -122.36

reports their ( at $16.00) first quarterly earnings report since their IPO(October 2, 2010) on November 4th after the close.. They will be touting , I'm sure , how far along they are in their new biofuel facilities in Brazil, as well as their joint venture partners, Vale, as well as other important companies invested with them. A video will be played 2 hrs after the report on their website.

aguadaboca (39.13) Submitted: 11/3/2010 3:27:50 PM : Start Price: $17.06 AMRS Score: -121.89

Sugar for energy! California company,17% owned by TOT(Total of France)which has joint venture with Santelisa Vale of Brazil. Was a recent IPO at $16.00, priced below initial expectations, and hasn't performed well since. This is a long term play and requires much patience! They are using yeast to turn sugar into biodiesal, which is more widely used than ethanol, and doesn't have the same trade restrictions that ethanol has, as it doesn't compete with corn production.